Skip to main content

Table 1 Main effects and interaction P values for drug and time analyzed by two-way ANOVA in Experiment I

From: Empagliflozin lessened cardiac injury and reduced visceral adipocyte hypertrophy in prediabetic rats with metabolic syndrome

Parameters (figure number) P time P drug P interaction
Body weight (Fig. 1a) <0.01 NS NS
24 h-food intake (Fig. 1b) <0.01 NS <0.01
24 h-water intake (Fig. 1c) <0.01 <0.01 <0.01
24 h-urine volume (Fig. 1d) <0.01 <0.01 <0.01
24 h-UGE (Fig. 1e) <0.01 <0.01 <0.01
24 h-urinary sodium excretion (Fig. 1f) <0.01 <0.01 <0.01
24 h-sodium balance (Fig. 2a) <0.01 <0.01 <0.01
Cumulative 24 h-sodium balance (Fig. 2b) <0.01 <0.01 <0.01
24 h-water balance (Fig. 2c) <0.01 <0.05 0.6951
Cumulative 24 h-water balance (Fig. 2d) <0.01 <0.05 <0.01
Body weight (Fig. 3a) <0.01 <0.05 <0.01
24 h-food intake (Fig. 3b) <0.01 <0.01 <0.01
24 h-water intake (Fig. 3c) <0.01 <0.01 <0.01
24 h-urine volume (Fig. 3d) <0.01 <0.01 <0.01
24 h-UGE (Fig. 3e) <0.01 <0.01 <0.01
24 h-urinary sodium excretion (Fig. 3f) <0.01 NS <0.01
24 h-sodium balance (Fig. 3g) <0.01 NS NS
24 h-water balance (Fig. 3h) <0.01 NS <0.01
  1. UGE urinary glucose excretion; NS not significant
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840